GL

Repricing health insurance and agency incentives aim to restore profitability after claims volatility tested margins.

PALO ALTO, Calif., Oct.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Globe Life disclosed roughly $7 million in excess prior-period Medicare Supplement claims linked to a federal CMS processing delay, and GL shares fell over 8%.

Insurance holding company Globe Life (NYSE:GL) met Wall Street’s revenue expectations in Q3 2026, with sales up 6% year on year to $1.61 billion. Its non-GAAP profit of $4.84 per share was 1.1% below analysts’ consensus estimates.

Key TakeawaysGlobe Life shares fell 8% after Piper Sandler downgraded the stock to Neutral from Overweight and cut its price target to $165 from $200.

Globe Life’s third quarter saw solid revenue growth, yet the market responded negatively after adjusted earnings came in below analyst expectations.

Globe Life stock barely flinched after Q3 2026 earnings, slipping about 0.7% to US$168.41 even as the insurer posted basic earnings per share of US$4.71 and net income of US$361.1m. Short-term traders see a quiet tape.

Globe Life (NYSE:GL) reported third-quarter net income of $361 million, or $4.62 per share, down 2% from $4.73 per share a year earlier. Net operating income rose 1% to $379 million, or $4.84 per share, compared with $4.81 per share in the prior-year quarter.